
About Deepar Pharmaceuticals
Deepar Pharmaceuticals is a Healthcare company. Pharmaceutical manufacturing and distribution of various health products in India. Its Indian entity Deepar Pharmaceuticals Private Limited reported revenue of βΉ8.30 Cr. Deepar Pharmaceuticals offers products and services including Tablets and Capsules. Its focus areas include Pharmaceuticals, Drug Manufacturing, Generic Medications and Medical Supplies.
Company details
Deepar Pharmaceuticals is recognized as a pharmaceutical company that was founded in 2009 and incorporated in 2016, with a focus on delivering innovative molecules to enhance healthcare in India. The company is led by its directors who have worked to build strong relationships with doctors and provide quality, affordable medicines. Products such as tablets, capsules, and syrups are manufactured under WHO and GMP certifications, ensuring adherence to high standards. A pan-India presence is maintained to make healthcare solutions accessible, emphasizing quality assurance and customer-focused approaches in operations.
- SectorsHealthcare
- Phoneβ’β’β’β’ β’β’β’β’
- Website deeparpharma.com
- Social X Facebook Instagram
- Legal Name Deepar Pharmaceuticals Pvt. Ltd
- Date of Incorporation 05 May, 2016
- Jurisdiction Jaipur, Rajasthan, India
- Indian entity revenue₹8.30 Cr
FY 2025 · +6% YoY
- Indian entity net profit₹12.4 Lakh
FY 2025 · 1% margin
- Indian entity EBITDA₹36.2 Lakh
FY 2025 · 4% margin
Associated legal entities of Deepar Pharmaceuticals
Deepar Pharmaceuticals operates through Deepar Pharmaceuticals Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Deepar Pharmaceuticals Private Limited CIN U24290RJ2016PTC054843 | Active | 05 May 2016 | Jaipur, Rajasthan | ₹8.3 Cr | 4 | View details |
Products & Services of Deepar Pharmaceuticals
Deepar Pharmaceuticals offers a comprehensive portfolio of products and services, including Tablets and Capsules.
Various tablets are manufactured for addressing health needs, including products like LIZO-600mg Tab and SENIFER-XT Tab
Capsules are produced for medicinal purposes, such as FUNGI 200mg Cap and SENOXY Cap
Board of directors of Deepar Pharmaceuticals Private Limited (Deepar Pharmaceuticals)
Deepar Pharmaceuticals Private Limited is the primary company behind Deepar Pharmaceuticals. The board of Deepar Pharmaceuticals Private Limited currently have 4 directors; the longest-serving is Nishant Arora, appointed in 2016.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Nishant Arora DIN 07494203 | Director | 05 May 2016 | 10 yrs 6 mo | Deepar Pharmaceuticals Private Limited |
| Sanjay Bansal DIN 07494117 | Director | 05 May 2016 | 10 yrs 6 mo | Deepar Pharmaceuticals Private Limited |
| Nisha DIN 07494157 | Director | 05 May 2016 | 10 yrs 6 mo | Deepar Pharmaceuticals Private Limited |
| Shradha Arora DIN 07494153 | Director | 05 May 2016 | 10 yrs 6 mo | Deepar Pharmaceuticals Private Limited |
Financials of Deepar Pharmaceuticals
Figures of Deepar Pharmaceuticals Private Limited, the primary company behind Deepar Pharmaceuticals, for FY 2025. Revenue was ₹8.30 Cr (+6% year on year). Net profit was ₹12.4 Lakh (1% margin). EBITDA was ₹36.2 Lakh (4% margin). Revenue has grown at a compounded annual rate of -6% over three years and +3% over five years.
- ₹8.30 CrRevenue · FY 2025 · +6% YoY
- ₹12.4 LakhNet profit · 1% margin
- ₹36.2 LakhEBITDA · 4% margin
- ₹1 LakhPaid-up capital
- -6%Revenue CAGR, 3 years
- +3%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Deepar Pharmaceuticals Private Limited are on its company page.
Detailed financial statements for Deepar Pharmaceuticals
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Deepar Pharmaceuticals
The primary company behind Deepar Pharmaceuticals, Deepar Pharmaceuticals Private Limited, reported revenue of βΉ8.30 Cr for FY 2025, up 6% year on year.
Deepar Pharmaceuticals is recognized as a pharmaceutical company that was founded in 2009 and incorporated in 2016, with a focus on delivering innovative molecules to enhance healthcare in India. The company is led by its directors who have worked to build strong relationships with doctors and provide quality, affordable medicines. Products such as tablets, capsules, and syrups are manufactured under WHO and GMP certifications, ensuring adherence to high standards. A pan-India presence is maintained to make healthcare solutions accessible, emphasizing quality assurance and customer-focused approaches in operations.
Deepar Pharmaceuticals offers Tablets and Capsules.
Deepar Pharmaceuticals operates through Deepar Pharmaceuticals Private Limited.
The legal entities of Deepar Pharmaceuticals currently have 4 directors, including Nishant Arora, Sanjay Bansal, Nisha and others.